asthma

AstraZeneca's Airsupra cuts risk of severe exacerbations by 47% in patients with milder asthma
Fierce Pharma
Mon, 05/19/25 - 10:22 pm
AstraZeneca
asthma
Airsupra
clinical trials
AstraZeneca's Breztri aces 2 asthma trials, lining it up for label expansion
Fierce Pharma
Sun, 05/4/25 - 12:05 pm
AstraZeneca
Breztri Aerosphere
asthma
clinical trials
AstraZeneca’s triple-combo triumphs in two Phase III asthma trials
Clinical Trials Arena
Fri, 05/2/25 - 10:50 am
AstraZeneca
Breztri Aerosphere
asthma
clinical trials
Sanofi's 'daughter of Dupixent' heads to phase 3 in asthma
Pharmaphorum
Tue, 04/15/25 - 09:53 am
Sanofi
Dupixent
clinical trials
asthma
amlitelimab
GSK asthma treatment shows reduced exacerbations: Study
Beckers Hospital Review
Sun, 03/16/25 - 09:50 pm
GSK
asthma
depemokimab
GSK gears up for depemokimab debut with twin FDA filings and phase 3 data dump
Fierce Biotech
Mon, 03/3/25 - 10:18 am
GSK
depemokimab
FDA
chronic rhinosinusitis with nasal polyps
asthma
Stopwatch starts on reviews of GSK's long-acting asthma drug
Pharmaphorum
Tue, 01/28/25 - 10:19 am
GSK
asthma
depemokimab
Europe
China
Japan
Fasenra shows benefit in acute asthma and COPD in Phase II trial
Clinical Trials Arena
Sun, 12/1/24 - 11:48 am
Fasenra
clinical trials
asthma
COPD
FDA finds widely used asthma drug impacts the brain, Reuters reports
CNBC
Fri, 11/22/24 - 11:11 am
Merck
FDA
asthma
Singulair
AstraZeneca heads to regulators after Airsupra asthma trial stops early thanks to 'overwhelming efficacy'
Fierce Pharma
Mon, 10/7/24 - 09:50 pm
AstraZeneca
Airsupra
asthma
GSK's long-acting asthma drug halved attacks in phase 3, backing up blockbuster hopes
Fierce Biotech
Mon, 09/9/24 - 11:14 am
GSK
asthma
clinical trials
depemokimab
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena
Thu, 05/23/24 - 10:58 am
Sanofi
clinical trials
rilzabrutinib
asthma
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential
Fierce Biotech
Wed, 05/15/24 - 11:21 am
Blackstone Life Sciences
Uniquity Bio
solrikitug
COPD
asthma
Senator Maggie Hassan Blasts GSK for Discontinuing Common Children’s Asthma Inhaler to Dodge Price Cap
Xtalks
Tue, 05/7/24 - 06:29 pm
GSK
Senate
asthma
pediatric
drug pricing
Flovent
GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month
Fierce Pharma
Thu, 03/21/24 - 06:37 pm
GSK
Boehringer Ingelheim
AstraZeneca
drug pricing
COPD
asthma
RAPT Therapeutics Shares Plunge Premarket on FDA Study Hold
Morningstar
Tue, 02/20/24 - 11:17 am
RAPT Therapeutics
clinical trials
FDA
zelnecirnon
asthma
atopic dermatits
Discontinued GSK asthma drug stirs frustrations
Beckers Hospital Review
Wed, 02/14/24 - 06:36 pm
GSK
asthma
Flovent
GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline
BioSpace
Tue, 01/9/24 - 09:50 am
GSK
Aiolos Bio
M&A
asthma
JPMHC 2024
Connect Biopharma plots phase 3 regulatory path after asthma asset hits mid-stage trial goals
Fierce Biotech
Tue, 12/12/23 - 11:21 am
Connect Biopharma
asthma
clinical trials
rademikibart
Aiolos Bio launches with ex-Gyroscope CEO at the helm, nearly $250M to advance severe asthma med
Fierce Biotech
Tue, 10/24/23 - 09:48 am
Aiolos Bio
funding
asthma
severe asthma

Pages